KIR3DL1
KIR3DL1 (killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1; also NKB1, CD158e1 and nkat3) is an inhibitory receptor on natural killer cells that recognises HLA Bw4 alleles. By inhibiting NK cell activity, it prevents cell lysis. Browse Assay Genie's current range of KIR3DL1 research reagents below, or read on for the biology behind the target.
KIR3DL1 is a receptor on natural killer (NK) cells for HLA Bw4 alleles. On binding its ligand it inhibits the activity of the NK cell and so prevents cell lysis. This makes it one of the receptors that lets NK cells distinguish healthy cells bearing HLA class I molecules from cells that lack them.
The KIR3DL1 protein belongs to the immunoglobulin superfamily and sits in the cell membrane. It is a member of the killer cell immunoglobulin-like receptor (KIR) family of transmembrane glycoproteins, which are expressed by NK cells and subsets of T cells. KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether the cytoplasmic domain is long (L) or short (S). The name KIR3DL1 follows this scheme: three Ig domains and a long cytoplasmic tail. Receptors with a long tail transduce inhibitory signals after ligand binding through an immune tyrosine-based inhibitory motif (ITIM). Short-tailed receptors lack the ITIM and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals.
The KIR3DL1 gene lies in the KIR gene cluster within the leukocyte receptor complex on chromosome 19q13.4. KIR genes are polymorphic and highly homologous, and gene content varies among haplotypes. Several framework genes, including KIR3DL3, KIR3DP1, KIR3DL4 and KIR3DL2, are found in all haplotypes. Because the ligands of several KIR proteins are subsets of HLA class I molecules, KIRs are thought to play an important role in regulating the immune response. The gene is also known as CD158e1/2, NKB1B, AMB11, cl-2 and cl-11, and the family is listed among the CD molecules.
KIR3DL1 is an inhibitory NK cell receptor that prevents cell lysis, so it is central to studies of how NK cell activity is restrained.
KIR3DL1 recognises HLA Bw4 alleles, making it a focus for work on how KIR proteins engage subsets of HLA class I molecules.
Its long cytoplasmic tail carries an ITIM that transduces inhibitory signals, a useful model for inhibitory receptor signalling.
KIR genes are polymorphic, highly homologous and vary in content among haplotypes, so KIR3DL1 is relevant to haplotype and diversity studies.
KIR3DL1 is a receptor on natural killer cells for HLA Bw4 alleles. When it engages its ligand it inhibits NK cell activity and so prevents cell lysis. Its long cytoplasmic tail transduces inhibitory signals through an immune tyrosine-based inhibitory motif (ITIM).
KIR3DL1 is also called NKB1, NKB1B, AMB11, nkat3, cl-2, cl-11 and CD158e1/2 (CD158E1, CD158e2). Its earlier HGNC name was killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1. The name describes three Ig domains and a long cytoplasmic tail.
Mouse and rat each have an orthologous gene named Kir3dl1. In humans the KIR genes are polymorphic and highly homologous, and gene content varies among haplotypes. Check the datasheet of any product for its validated reactivity.
Other killer cell immunoglobulin-like receptors, including framework KIR family members, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P43629; product specifications from Assay Genie datasheets.